Ricoh launches Ricoh 3D for Healthcare, LLC to accelerate patient-specific device adoption

by Medical

Ricoh USA, the North American arm of the Japanese digital services multinational, has announced the formation of Ricoh 3D for Healthcare, LLC, a new legal entity dedicated to delivering FDA-cleared, patient-specific 3D printed medical devices at hospitals across the United States. The company, unveiled on June 17, 2025, will enhance Ricoh’s ability to meet growing clinical demand for personalized care, streamline regulatory compliance, and support point-of-care manufacturing.

3D Printed Motor Neuron Organoids by Uppsala Researchers Could Accelerate ALS Drug Development

by Medical

Researchers at Uppsala University in Sweden have developed 3D printed models from patient-derived cells to simulate motor neurons in the lab. These structures, known as motor neuron organoids, are expected to support research into neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and help explore treatment strategies without the need for invasive procedures.

Stanford Develops 3D Printing Algorithm to Advance Vascular Design for Organ Bioprinting

by Medical

Stanford researchers have taken a major step toward addressing one of the biggest hurdles in organ bioprinting: building realistic vascular networks capable of sustaining lab-grown tissue. Their new platform, published June 12 in Science, accelerates the design of these blood vessel systems and translates them into 3D printable models—bringing the promise of personalized, functional organs closer to reality.

UltraThineer Veneers Offer Solution for Severe Tetracycline Staining

by Medical

UltraThineer, a 3D printing-based dental product developed by Boston Micro Fabrication (BMF), has demonstrated success in treating severe tetracycline staining through a recent clinical case. Dr. Tai Ha at Newport Beach Dental Studio applied UltraThineer’s no-prep, zirconia veneers to rehabilitate a 49-year-old patient dissatisfied with her smile due to deep intrinsic discoloration from childhood antibiotic use.

16d06576ab837b8a489478d34ab01fd5.jpg

U.S. Army and University of Hawaii Forge Alliance to Advance Biomaterials and Defense Manufacturing

by Medical

The U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) and the University of Hawaii System recently formalized a collaborative initiative to enhance warfighter survivability and effectiveness. This partnership, strategically focused on leveraging biomaterials and advanced manufacturing capabilities, aims to strengthen defense efforts, particularly in support of the United States Indo-Pacific Command, which is headquartered in Hawaii.